{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00239",
      "entity_text" : "cetuximab",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:B7ZLG1",
      "entity_text" : "FOXP3",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "For example, CD4 + FOXP3 + intratumoral Treg cells were shown to suppress cetuximab mediated ADCC (antibody dependent cellular cytotoxicity) and were correlated with poor clinical outcome in two prospective clinical trial cohorts XREF_BIBR.",
  "reading_complete" : "2020-08-03T16:10:59Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T16:09:29Z",
  "trigger" : "suppress",
  "evidence" : [ "FOXP3 +  intratumoral Treg cells were shown to suppress cetuximab" ],
  "pmc_id" : "6096398",
  "score" : 0
}